Design and Synthesis of 2-Arylbenzimidazoles and Evaluation of Their Inhibitory Effect against Chlamydia pneumoniae.

C.Pneumoniae is very resistant to antibiotics and new drugs are needed.These are examples of work in the pharmaceutical industry
Enhanced by Zemanta

No comments: